← Back to Search

Biomarker Test

Usual care (Arm B) for Rheumatoid Arthritis

N/A
Waitlist Available
Research Sponsored by Crescendo Bioscience
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 months
Awards & highlights

Study Summary

This study is evaluating whether a combination of two drugs may help individuals with rheumatoid arthritis.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in DAS28 at Month 6
Percentage of subjects using any biologic DMARD or JAK inhibitor to Month 6
Secondary outcome measures
Change in HAQ-DI score at Month 6
Percentage of subjects with ACR20 response at Month 6
Percentage of subjects with radiographic non-progression at 12 months
+2 more
Other outcome measures
Change in HAQ-DI score at Month 12
Change in health related QOL as measured by EQ-5D-5L at Month 12
Change in health related QOL as measured by EQ-5D-5L at Month 6
+13 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Vectra DA (Arm A)Experimental Treatment1 Intervention
Treatment intensification with non-biologic DMARDS guided by Vectra DA
Group II: Usual care (Arm B)Experimental Treatment1 Intervention
Treatment intensification by usual care without using Vectra DA

Find a Location

Who is running the clinical trial?

Crescendo BioscienceLead Sponsor
1 Previous Clinical Trials
1,600 Total Patients Enrolled
1 Trials studying Rheumatoid Arthritis
1,600 Patients Enrolled for Rheumatoid Arthritis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care
2016. "Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02832297.
~36 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top